May/June 2023

May/June 2023 Pharma Manufacturing

Surrendering to the pharma magic

July 17, 2023
The science of ADCs makes for an incredible show
Pm2306 Hero 854x480 Quality

From paper errors to high-tech excellence

July 6, 2023
How pharma can use digital tools to modernize data integrity
Shutterstock 359614955

Drug packaging keeps pace

July 5, 2023
How future industry trends will influence pharma packaging needs
Pm2306 Hero 854x480 Automation

Transitioning to precision medicine

June 27, 2023
Moving away from one-size-fits-all treatments will require pharma to view data holistically
Shutterstock 1664010940

Engineering angles: Embracing BIM in pharma plant design

June 26, 2023
It’s time for the industry to overcome hesitations and utilize 3D technology

More content from May/June 2023

Pm2306 Hero 854x480 Operations

Adapting drug delivery for distance-care

June 22, 2023
Advancements in patient-operated delivery systems offer safety and convenience
Shutterstock 2025641213

AI beyond drug development

June 15, 2023
How artificial intelligence can streamline pharma procurement and supply chain management
Screen Shot 2023 06 14 At 12 13 06 Pm

Spring pharma happenings: PDA’s Annual Meeting 2023

June 14, 2023
Through discussions that focused on innovative operational approaches as well as powerful patient-hosted sessions, the show sought to remind manufacturers to keep a patient-focused...
Pm Article Option 4

7 challenges of NGS-based biomarkers

June 13, 2023
Next generation sequencing has unprecedented power in biology, but has yet to reach its full potential in medicine
Pm22 Hero 854x480 Act1 Cover Story

The great reappearing act: ADCs' triumphant return

June 9, 2023
In our three-part series, we cover the trajectory of cancer-fighting ADCs in the pharma industry, including the modality’s history, obstacles and success stories
Microsoft Teams Image (1)

The great reappearing act: ADCs light up the stage

June 9, 2023
In the third and final part of our series on antibody-drug conjugates, we discuss the recent market buzz and the rise of new conjugated modalities.
Pm22 Hero 854x480 Act2 Cover Story

The great reappearing act: ADCs' new bag of tricks

June 9, 2023
In Act 2 of our series on antibody-drug conjugates, we cover improved linker and payload technology